Urogenital atrophy

Menopause International

Volumn 14, Issue 3, 2008, Pages 136-137

  Pitkin, Joan ^a   Rees, Margaret ^a  

^a British Menopause Society Council

Author keywords

Ageing; bioadhesive moisturizers; postreproductive health; urogenital atrophy; vaginal estrogen

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR; GESTAGEN; LACTIC ACID; LUBRICATING AGENT; POLYCARBOPHIL; PROGESTERONE RECEPTOR; SYLK; UNCLASSIFIED DRUG;

AGING; ATROPHY; CANCER RISK; CONDOM; DYSPAREUNIA; ENDOMETRIUM CANCER; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HUMAN; LONG TERM CARE; LOW DRUG DOSE; LUBRICATION; PATHOPHYSIOLOGY; REPRODUCTIVE HEALTH; SHORT SURVEY; STRESS INCONTINENCE; URGE INCONTINENCE; URINARY TRACT INFECTION; UROGENITAL ATROPHY; UROGENITAL TRACT DISEASE; VAGINA EPITHELIUM; VAGINA PESSARY; VAGINA SECRETION; VAGINAL DRYNESS; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN RELATION; MENOPAUSE; PATHOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; UNITED KINGDOM; UROGENITAL SYSTEM; WOMEN'S HEALTH;

ATROPHY; FEMALE; FEMALE UROGENITAL DISEASES; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; PATIENT EDUCATION AS TOPIC; PROFESSIONAL-PATIENT RELATIONS; UROGENITAL SYSTEM; WOMEN'S HEALTH;

EID: 56149092512     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2008.008022     Document Type: Article

References (25)

1. Michel JP, Newton JL, Kirkwood TB. Medical challenges of improving the quality of a longer life. JAMA 2008; 299: 688–90
2. Willhite LA, O' Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001; 21: 464–80
3. van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50–75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 9–14
4. Oskay UY, Beji NK, Yalcin O. A study on urogenital complaints of postmenopausal women aged 50 and over. Acta Obstet Gynecol Scand 2005; 84: 72–78
5. American College of Obstetricians and Gynecologists Women's Health Care Physicians. Genitourinary tract changes. Obstet Gynecol 2004; 104: 56S–61S
6. Bygdeman M, Swahn ML. Replens versus dienoestriol cream in the symptomatic treatment of vaginal atrophy in post menopausal women. Maturitas 1996; 23: 259–63
7. Rosen AD, Rosen T. Study of condom integrity after brief exposure to over-the-counter vaginal preparations. South Med J 1999; 92: 305–7
8. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005; 52: S46–S52
9. Simunic V, Banovic I, Ciglar S,, et al Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003; 82: 187–97
10. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006; 4: CD001500
11. Nelson HD, Haney E, Humphrey L,, et al Management of menopause-related symptoms. Evid Rep Technol Assess (Summ) 2005; 120: 1–6
12. Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008; 111: 67–76
13. Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000; 7: 156–61
14. CKS. Clinical Topic. Menopause. See [http://www.cks.library.nhs.uk/menopause] ( last accessed 27 May 2008)
15. Notelovitz M, Funk S, Nanavati N, Mazzeo M. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol 2002; 99: 556–62
16. Santen RJ, Pinkerton JV, Conaway M, Ropka M, Wisniewski L, Demers L, Klein KO. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause 2002; 9: 179–87
17. Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O'Neill S, Kirkegard Y, Fraser IS, Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005; 8: 83–92
18. Waaseth M, Bakken K, Dumeaux V, Olsen KS, Rylander C, Figenschau Y, Lund E. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort – a cross-sectional analysis. BMC Womens Health 2008; 8: 1
19. Rees M, Purdie DW. Management of the Menopause. The Handbook 2006. London, UK: RSM Press, 2006
20. Weiderpass E, Baron JA, Adami HO,, et al Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet 1999; 353: 1824–8
21. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998; 92: 722–7
22. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008; 2: CD005131
23. Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994; 83: 12–18
24. Wright TC, Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120–9
25. Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; for the 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007; 11: 201–22